Pieter Annaert

10.0k total citations
237 papers, 7.6k citations indexed

About

Pieter Annaert is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Pieter Annaert has authored 237 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 73 papers in Pediatrics, Perinatology and Child Health and 53 papers in Infectious Diseases. Recurrent topics in Pieter Annaert's work include Drug Transport and Resistance Mechanisms (87 papers), Pharmacological Effects and Toxicity Studies (42 papers) and HIV/AIDS drug development and treatment (34 papers). Pieter Annaert is often cited by papers focused on Drug Transport and Resistance Mechanisms (87 papers), Pharmacological Effects and Toxicity Studies (42 papers) and HIV/AIDS drug development and treatment (34 papers). Pieter Annaert collaborates with scholars based in Belgium, Netherlands and United States. Pieter Annaert's co-authors include Patrick Augustijns, Joachim Brouwers, Jan Tack, Raf Mols, Johan A. Martens, Jan Van Humbeeck, Guy Van den Mooter, Guy Van den Mooter, Randy Mellaerts and Isabel Spriet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Physiology.

In The Last Decade

Pieter Annaert

225 papers receiving 7.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pieter Annaert 1.9k 1.9k 1.4k 1.3k 1.2k 237 7.6k
James E. Polli 2.6k 1.4× 2.0k 1.1× 1.2k 0.9× 1.5k 1.1× 701 0.6× 198 7.0k
Werner Siegmund 910 0.5× 2.7k 1.4× 1.5k 1.1× 1.1k 0.8× 1.0k 0.9× 185 6.3k
Arik Dahan 3.3k 1.7× 1.9k 1.0× 604 0.4× 1.3k 1.0× 647 0.5× 135 6.6k
Patrick J. Sinko 1.5k 0.8× 2.2k 1.1× 752 0.6× 2.8k 2.1× 527 0.4× 177 8.0k
Peter Langguth 3.3k 1.7× 1.9k 1.0× 954 0.7× 2.2k 1.7× 862 0.7× 271 9.1k
Kishor M. Wasan 1.5k 0.8× 952 0.5× 353 0.3× 2.1k 1.5× 381 0.3× 238 7.6k
William N. Charman 7.4k 3.8× 2.6k 1.3× 1.1k 0.8× 3.6k 2.7× 1.2k 1.0× 170 14.8k
Andrew Owen 565 0.3× 1.6k 0.8× 1.4k 1.1× 1.2k 0.9× 746 0.6× 324 8.1k
Valentino J. Stella 3.1k 1.6× 1.2k 0.6× 594 0.4× 2.7k 2.0× 463 0.4× 185 9.0k
Su Zeng 1.2k 0.6× 1.8k 0.9× 447 0.3× 4.2k 3.1× 1.6k 1.3× 392 9.7k

Countries citing papers authored by Pieter Annaert

Since Specialization
Citations

This map shows the geographic impact of Pieter Annaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Annaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Annaert more than expected).

Fields of papers citing papers by Pieter Annaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Annaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Annaert. The network helps show where Pieter Annaert may publish in the future.

Co-authorship network of co-authors of Pieter Annaert

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Annaert. A scholar is included among the top collaborators of Pieter Annaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Annaert. Pieter Annaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Annaert, Pieter, Paul Clarke, Isabel Iglesias‐Platas, et al.. (2025). Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates. The Journal of Clinical Pharmacology. 65(7). 923–932.
2.
Smits, Anne, et al.. (2025). Predicting Drug Transfer Into Human Milk With the Simcyp Simulator: A Contribution From the ConcePTION Project. CPT Pharmacometrics & Systems Pharmacology. 14(9). 1470–1484.
3.
4.
5.
Loy, Tom Van, Mike Sathekge, Christophe M. Deroose, et al.. (2024). Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging. Nuclear Medicine and Biology. 132-133. 108906–108906. 3 indexed citations
6.
Vos, Kristof De, Justina C. Wolters, Susan Schlenner, et al.. (2024). Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells. Biochemical Pharmacology. 227. 116445–116445. 1 indexed citations
7.
Annaert, Pieter, Anne Smits, Karel Allegaert, et al.. (2024). Drug Disposition in Neonatal Göttingen Minipigs: Exploring Effects of Perinatal Asphyxia and Therapeutic Hypothermia. Drug Metabolism and Disposition. 52(8). 824–835.
8.
Duthaler, Urs, Pieter Annaert, Stephen Fowler, et al.. (2023). Dose Adjustment in Patients with Liver Cirrhosis – Comparison of Two Different Modeling Approaches. Clinical Pharmacology & Therapeutics. 113(6). 1346–1358. 9 indexed citations
9.
Qi, Bing, et al.. (2023). Unravelling the Hepatic Elimination Mechanisms of Colistin. Pharmaceutical Research. 40(7). 1723–1734. 1 indexed citations
10.
Gijsen, Matthias, Pieter Annaert, Ruth Van Daele, et al.. (2022). Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function. SHILAP Revista de lepidopterología. 18 indexed citations
11.
Keleş, Elif, Pia Wintermark, Floris Groenendaal, et al.. (2022). Serum Creatinine Patterns in Neonates Treated with Therapeutic Hypothermia for Neonatal Encephalopathy. Neonatology. 119(6). 686–694. 12 indexed citations
12.
Gijbels, Eva, et al.. (2021). Biomarkers of Cholestasis. Biomarkers in Medicine. 15(6). 437–454. 20 indexed citations
13.
Smits, Anne, Pieter Annaert, Giacomo Cavallaro, et al.. (2021). Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. British Journal of Clinical Pharmacology. 88(12). 4965–4984. 30 indexed citations
14.
Gijsen, Matthias, Pieter Annaert, Yves Debaveye, et al.. (2021). Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation. Antibiotics. 10(4). 449–449. 10 indexed citations
15.
Bernardini, Chiara, Roberta Salaroli, Augusta Zannoni, et al.. (2021). Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier—A Contribution from the IMI-ConcePTION Project. Animals. 11(7). 2012–2012. 6 indexed citations
16.
Smits, Anne, et al.. (2020). Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation. British Journal of Clinical Pharmacology. 87(4). 2089–2097. 8 indexed citations
17.
Qi, Bing, et al.. (2019). A sensitive liquid chromatography method for analysis of propofol in small volumes of neonatal blood. Journal of Clinical Pharmacy and Therapeutics. 45(1). 128–133. 5 indexed citations
18.
Qi, Bing, Eva Gijbels, Mathieu Vinken, et al.. (2019). Current insights in the complexities underlying drug-induced cholestasis. Critical Reviews in Toxicology. 49(6). 520–548. 20 indexed citations
19.
Russo, Francesca Maria, Karel Allegaert, Tim Van Mieghem, et al.. (2018). Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model. American Journal of Obstetrics and Gynecology. 219(6). 619.e1–619.e10. 20 indexed citations
20.
Vanhove, Thomas, Mahmoud Hasan, Pieter Annaert, Stefan Oswald, & Dirk Kuypers. (2017). Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation. British Journal of Clinical Pharmacology. 83(11). 2406–2415. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James E. Polli Breakdown of academic impact, for papers by Werner Siegmund Breakdown of academic impact, for papers by Arik Dahan Breakdown of academic impact, for papers by Patrick J. Sinko Breakdown of academic impact, for papers by Peter Langguth Breakdown of academic impact, for papers by Kishor M. Wasan Breakdown of academic impact, for papers by William N. Charman Breakdown of academic impact, for papers by Andrew Owen Breakdown of academic impact, for papers by Valentino J. Stella Breakdown of academic impact, for papers by Su Zeng
Rankless by CCL
2026